For informational purposes only.
Remogliflozin etabonate is a sodium-glucose co-transporter 2 (sglt2) inhibitors, a class of oral hypoglycaemic agents.
Teneligliptin is an dipeptidyl peptidase 4 (DPP-4) inhibitors class antidiabetic drugs.
Remogliflozin Etabonate and Teneligliptin tablet is prescribed to control high blood sugar levels in type 2 diabetes mellitus for adult patients above 18 years of age.
Dosage Forms & Strengths :-
Remogliflozin Etabonate 100 mg and Teneligliptin 20 mg fixed dose combination tablets for oral use.
Remogliflozin Etabonate and Teneligliptin tablet Uses :-
Remogliflozin etabonate tablet is an antidiabetic drugs, used to control type 2 diabetes mellitus (high blood sugar levels) in adult patients above 18 years of age.
Remogliflozin etabonate tablet can be used alone or in combination with other antidiabetic drugs.
When Remogliflozin etabonate tablet is used along with a healthy diet and exercise, it helps a lot in controlling blood sugar.
Remogliflozin Etabonate and Teneligliptin tablet Dosage :-
Remogliflozin Etabonate and Teneligliptin tablet is a prescription medicine. Take Remogliflozin etabonate tablet as directed by your doctor.
Use Remogliflozin Etabonate and Teneligliptin tablet exactly as directed by the doctor. Do not take a higher or lower dose than directed by your doctor.
Remogliflozin Etabonate and Teneligliptin tablet should be taken immediately before or with a meal. Never self-medicate or change the dosage without a doctor's advice.
Do not take 2 or more doses at the same time.
Always try to take Remogliflozin Etabonate and Teneligliptin tablet on regular schedule. Always take the tablet even if you feel well or your blood sugar level is under control. Do not stop taking without your doctor's advice. Otherwise, your blood sugar level may rise again. Do not stop taking Remogliflozin Etabonate and Teneligliptin tablet without asking your doctor. Because the treatment of diabetes is lifelong.
How Does Remogliflozin Etabonate and Teneligliptine Work :-
When single combination drugs are ineffective in controlling blood glucose levels, than combination drugs are used.
These combination drugs then help to work by different mechanisms to provide better control of blood sugar.
Remogliflozin etabonate :
Remogliflozin Etabonate reduces excess sugar from your body through urine.
Remogliflozin Etabonate reduce the amount of glucose in the blood. Remogliflozin etabonate works by controlling the level of sugar in blood and help in reducing the level of blood sugar.
Teneligliptin is an dipeptidyl peptidase 4 (DPP-4) inhibitors class antidiabetic drugs. Teneligliptin works by increasing the amount of insulin produced by pancreas. Teneligliptin works by decreasing the hormones that raise blood sugar levels in the pancreas. Teneligliptin lowers your blood sugar level, and controls the amount of glucose in the blood.
Thus Remogliflozin Etabonate and Teneligliptin fixed dose combination drugs works by controlling the level of sugar in the blood.
Remogliflozin Etabonate and Teneligliptin Tablet Sideeffects :-
Like all medicines, Remogliflozin Etabonate and Teneligliptin tablet can cause side effects, however not everyone may experience these side effects.
Some common side effects of Remogliflozin Etabonate :
Low blood sugar (hypoglycemia),
Urinary tract infections,
Nervousness or anxiety,
Irritability to sweat,
Weight loss,
Dizziness or headache,
Fatigue or fatigue genital fungal infection
Feeling hungry and many other side effects can occur.
Low blood sugar (hypoglycemia),
Constipation,
Dizziness,
Diarrhea,
Fever,
Remogliflozin Etabonate and Teneligliptin Combination Brands :
Safety Advice :-
Pregnancy - As recommended by your doctor,
Information regarding the use of Remogliflozin etabonate tablet during pregnancy is not available. Please consult your doctor for this.
Breastfeeding - As recommended by your doctor,
No information is available on the use of Remogliflozin etabonate tablet during lactation. Please consult your doctor for this.
Kidney - As recommended by your doctor,
There is limited information available on the use of Remogliflozin etabonate tablet in patients with kidney disease. Please consult your doctor for this.
Liver - As recommended by your doctor,
There is limited information available on the use of Remogliflozin etabonate tablet in patients with liver disease. Please consult your doctor for this.
Alcohol - As recommended by your doctor,
It is not known whether it is safe to consume alcohol with Remogliflozin etabonate tablet, please consult your doctor.
Classification :-
Therapeutic Class - Antidiabetic drugs, dipeptidyl peptidase 4 (DPP-4) inhibitors and Sodium-glucose co-transporter 2 (sglt2) inhibitors.
Information on this page was last updated on 17 September 2021